Cancer
Data from the Medical University of South Carolina show that despite guidelines recommending extended pharmacologic prophylaxis for 30 days after surgery, the adoption of this practice remains low among patients undergoing major cancer surgery. A single-center retrospective cohort study analyzed data from 5246 patients and found that only 17.1%
Cancer research
A comprehensive study published in the journal eClinicalMedicine has highlighted the association between endometriosis and uterine fibroids, with women with endometriosis showing a 2.91 to 10.41 times higher odds of developing fibroids compared to controls. The study, funded by the Italian Ministry of Health, systematically searched PubMed, Embase,
Cancer research
Researchers at the University of Genoa in Italy have made significant contributions to the understanding of PD-L1 expression in gastric cancer. A new report presents findings from a multicentric, real-world retrospective study that analyzed data from 28 Italian pathology centers, covering 1936 cases of esophageal, esophagogastric junction, and gastric carcinoma
Cancer research
Researchers at the Federal University in Brazil have developed a specialized care program for hereditary cancer patients, aiming to provide accessible and precise medical treatment through a structured care flow. The program, designed to identify suspected cases, provides genetic counseling, psychological support, and clinical follow-up. Financial support for this research
Cancer research
Recent research from the University of Tuzla has shed light on the connection between preoperative anemia and postoperative delirium in patients undergoing surgery for colorectal cancer. Conducted by a team of researchers, the study aimed to examine the relationship between preoperative anemia and postoperative delirium in patients surgically treated for
Bristol-Myers Squibb Co.
Researchers at Bristol-Myers Squibb Company and other institutions have identified complete response/remission (CR) rate as a potential surrogate endpoint in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). The study, published in Leukemia Research, analyzed data from 20 randomized controlled trials (RCTs) involving
Cancer research
Researchers at Capital Medical University conducted a retrospective study to evaluate the external validity of four venous thromboembolism (VTE) risk assessment models in Chinese patients undergoing colorectal cancer surgery. The study analyzed demographic characteristics, clinical data, and postoperative VTE status of 323 patients from January 2020 to December 2023. The
Cancer
Research conducted by the National Cancer Institute (NCI) has shown that cancer risk among people with HIV (PWH) has varied across different racial/ethnic and transmission risk groups. The study, which analyzed data from PWH aged 20 years during 2001-2019, found significant differences in cancer incidence rates among different racial/
Cancer
Researchers at the Federal University of Sergipe, Sao Cristovao, Brazil, have made significant findings on the integration of nanotechnology with natural products for developing cancer treatments and immunotherapies. Their study, published in the Beilstein Journal of Nanotechnology, reveals that nanotechnology provides significant advantages in controlling drug release, enhancing stability, and
Cancer research
A major international trial, led by researchers from the University of College London (UCL), has found that a new combination of drugs significantly delays the progression of a life-threatening form of prostate cancer in men with specific genetic mutations. The Phase III AMPLITUDE trial tested the addition of niraparib, a
Cancer research
A comprehensive study published in the journal eClinicalMedicine has highlighted the association between endometriosis and uterine fibroids, with women with endometriosis showing a 2.91 to 10.41 times higher odds of developing fibroids compared to controls. The study, funded by the Italian Ministry of Health, systematically searched PubMed, Embase,
Cancer cells
A team of researchers at the University of Bonn has made a groundbreaking discovery in the field of ovarian cancer treatment. In a study published in Cell Death Discovery, the researchers investigated the efficacy of PARP inhibitors in treating ovarian cancer cells that are resistant to cisplatin, a commonly used
